Glycemic variability in type 2 diabetes mellitus and acute coronary syndrome: liraglutide compared with insulin glargine: a pilot study

scientific article published on 01 June 2020

Glycemic variability in type 2 diabetes mellitus and acute coronary syndrome: liraglutide compared with insulin glargine: a pilot study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/0300060520926063
P932PMC publication ID7309403
P698PubMed publication ID32567433

P50authorMaría Isabel Del Olmo-GarciaQ88878729
P2093author name stringAlba Cerveró Rubio
Ana Catalá Gregori
Antonio Ballesteros Martin-Portugués
David Hervás Marín
Jana Caudet Esteban
Juan Francisco Merino-Torres
Maite Penalba Martínez
Miguel Angel Arnau Vives
P2860cites workImpact of admission glycemic variability, glucose, and glycosylated hemoglobin on major adverse cardiac events after acute myocardial infarctionQ36720262
P275copyright licenseCreative Commons Attribution-NonCommercial 4.0 InternationalQ34179348
P6216copyright statuscopyrightedQ50423863
P433issue6
P921main subjectacute coronary syndromeQ266018
insulin glargineQ417317
type 2 diabetesQ3025883
P304page(s)300060520926063
P577publication date2020-06-01
P1433published inJournal of International Medical ResearchQ15758331
P1476titleGlycemic variability in type 2 diabetes mellitus and acute coronary syndrome: liraglutide compared with insulin glargine: a pilot study
P478volume48

Search more.